Drug development clinical trial sites

Miss. Code Ann. § 41-155-17, under Ibogaine Drug Development Clinical Trial Act.

Miss. Code Ann. § 41-155-17

For purposes of conducting an ibogaine drug development clinical trial under this chapter, only an institution of higher learning or a hospital may serve as a trial site.